Nutrien Announces Completion of Tender Offer and Debt Redemptions; Accelerates Repurchase of Shares
Nutrien announced the settlement of $1.8 billion in debt securities and a cash tender offer to repurchase up to $300 million in debt. The offer saw $703.9 million in notes tendered, reflecting strong shareholder support. CFO Pedro Farah highlighted the use of free cash to enhance the balance sheet and increase shareholder returns, including a significant acceleration in share buybacks. The tender offer, which expired on December 14, 2021, was fully subscribed, demonstrating confidence in the company's robust agricultural market outlook for 2022.
- Settlement of $1.8 billion in debt securities strengthens balance sheet.
- Successful tender offer resulted in $703.9 million in notes tendered.
- Increased shareholder returns through accelerated share buybacks.
- Only 4.7% of Nutrien's 5.250% Senior Notes due 2045 were accepted in the tender offer, potentially limiting liquidity for that series.
all amounts are in US dollars
“We utilized our strong free cash in 2021 to meaningfully strengthen our balance sheet, providing flexibility to grow the business and return cash to shareholders through the cycle. Agriculture market fundamentals remain strong and we are confident in the outlook for the business in 2022. We remain committed to providing superior shareholder returns. As such, we have accelerated the pace of our share buybacks in the fourth quarter and expect to complete a significant portion of our existing normal course issuer bid that expires on
The Tender Offer
An aggregate principal amount of
Title of Security |
Issuer |
CUSIP / ISIN
|
Principal Amount
|
Acceptance
|
Principal
|
Principal
|
Final
|
|||||||
|
|
|
|
008916 AC2/ US008916AC28 |
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
008916 AG3/ US008916AG32 |
|
|
|
2 |
|
|
|
|
|
— |
|
|
|
|
008916 AJ7/ US008916AJ70 |
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
008916 AN8/ US0089AN82 |
|
|
|
4 |
|
|
|
|
|
|
|
|
|
|
67077M AP3/ US67077MAP32 |
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
67077M AQ1/ US67077MAQ15 |
|
|
|
6 |
|
|
|
|
|
|
|
|
|
|
67077M AS7/ US67077MAS70 |
|
|
|
7 |
|
|
|
|
|
|
|
|
|
|
73755L AD9/ US73755LAD91 |
|
|
|
8 |
|
|
|
|
|
— |
|
|
|
|
67077M AF5/ US67077MAF59 |
|
|
|
9 |
|
|
|
|
|
— |
|
|
|
|
73755L AK3/ US73755LAK35 |
|
|
|
10 |
|
|
|
|
|
— |
|
|
|
|
67077M AG3/ US67077MAG33 |
|
|
|
11 |
|
|
|
|
|
— |
(1) The final proration factors have been rounded to the nearest tenth of a percentage point for presentation purposes. Proration factors are only provided where notes of a series were accepted for purchase.
The amount of each series of Notes purchased was determined under the terms and conditions set forth in the offer to purchase, dated
The Early Tender Time and the Withdrawal Deadline for the Offer was
Capitalized terms used in this press release and not defined herein have the meanings given to them in the Offer to Purchase.
The Redemptions
Title of Security |
Issuer |
CUSIP / ISIN Numbers |
Principal Amount
|
Redemption Price (1) |
||||
|
|
67077M AK4 / US67077MAK45 |
|
|
||||
|
|
008916 AL2 / US008916AL27 |
|
|
||||
|
|
67077M AC2 / US67077MAC29 |
|
|
||||
|
|
73755L AL1 / US73755LAL18 |
|
|
||||
|
|
67077M AL2 / US67077MAL28 |
|
|
||||
|
|
008916 AP3 / US008916AP31 |
|
|
(1) Per
About
Forward-Looking Statements
Certain statements and other information included in this press release constitute "forward-looking information" or "forward-looking statements" (collectively, "forward-looking statements") under applicable securities laws (such statements are often accompanied by words such as "“anticipate”, “forecast”, “expect”, “believe”, “may”, “will”, “should”, “estimate”, “intend” or other similar words). All statements in this press release, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to expectations with respect to our normal course issuer bid. Forward-looking statements in this press release are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such forward-looking statements. The key risks and uncertainties are set forth in the Offer to Purchase, in the relevant documents incorporated by reference in the Offer to Purchase, and in
The Company disclaims any intention or obligation to update or revise any forward-looking statements in this press release as a result of new information or future events, except as may be required under applicable
View source version on businesswire.com: https://www.businesswire.com/news/home/20211216005878/en/
Investor Relations:
Vice President, Investor Relations
(306) 933-8545
investors@nutrien.com
Director, Investor Relations
(306) 933-8548
Media Relations:
Vice President,
(403) 797-3015
Contact us at: www.nutrien.com
Source:
FAQ
What is Nutrien's stock symbol?
What was the total amount of debt securities settled by Nutrien?
How much did Nutrien intend to repurchase in the cash tender offer?
What percentage of the Nutrien 5.250% Senior Notes due 2045 were accepted in the tender offer?